Pulmonary hypertension (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pulmonary hypertension" in English language version.

refsWebsite

Global rank English rank

107nih.gov

4^th place

68doi.org

2^nd place

24web.archive.org

1^st place

7semanticscholar.org

11^th place

8^th place

4medscape.com

719^th place

636^th place

2books.google.com

3^rd place

2choosingwisely.org

7,197^th place

4,379^th place

2fda.gov

447^th place

338^th place

2jnj.com

low place

2archive.org

6^th place

1lung.org

low place

1who.int

195^th place

302^nd place

1handle.net

102^nd place

76^th place

1radiopaedia.org

4,968^th place

3,180^th place

1medlineplus.gov

1,581^st place

1,299^th place

1merck.com

6,464^th place

5,671^st place

1reuters.com

49^th place

47^th place

1cbsnews.com

108^th place

80^th place

1gilead.com

low place

1news-medical.net

8,069^th place

7,681^st place

1ustransplant.org

low place

1patient.info

low place

7,180^th place

1oxfordjournals.org

1,389^th place

2,996^th place

1nydailynews.com

134^th place

100^th place

1latimes.com

22^nd place

19^th place

1nypost.com

208^th place

156^th place

1huffingtonpost.com

109^th place

87^th place

archive.org

Kaufman MH, Stead L, Feig R (2007). First aid for the obstetrics & gynecology clerkship. New York: McGraw-Hill, Medical Pub. Division. p. 100. ISBN 978-0-07-144874-1.
Ghosh AK (2008). Mayo Clinic Internal Medicine Review. Mayo Clinic Internal Medicine Review (8th ed.). Informa Healthcare. p. 55. ISBN 978-1-4200-8478-8.

books.google.com

Yusuf S, Cairns J, Camm J, Fallen EL, Gersh BJ (2011-09-07). Evidence-Based Cardiology. John Wiley & Sons. p. 70.3(figure). ISBN 978-1-4443-5945-9. Archived from the original on 2016-04-30.
Klepper MJ, Cobert B (2010-10-25). Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk. Jones & Bartlett Learning. p. 86. ISBN 978-0-7637-6912-3. Archived from the original on 2016-05-04.

cbsnews.com

"Citing Liver Damage, Pfizer Withdraws Thelin - CBS Detroit". www.cbsnews.com. 10 December 2010.

choosingwisely.org

American College of Chest Physicians; American Thoracic Society (September 2013), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American College of Chest Physicians and American Thoracic Society, archived from the original on 3 November 2013, retrieved 6 January 2013, which cites
- McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. (April 2009). "ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association". Circulation. 119 (16): 2250–94. doi:10.1161/CIRCULATIONAHA.109.192230. PMID 19332472.
- American College of Chest Physicians; American Thoracic Society (September 2013), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American College of Chest Physicians and American Thoracic Society, archived from the original on 3 November 2013, retrieved 6 January 2013

doi.org

Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RM, Brida M, et al. (October 2022). "2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension". European Heart Journal. 43 (38): 3618–3731. doi:10.1093/eurheartj/ehac237. PMID 36017548.
Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, et al. (June 2009). "Updated clinical classification of pulmonary hypertension". Journal of the American College of Cardiology. 54 (1 Suppl): S43–S54. doi:10.1016/j.jacc.2009.04.012. PMID 19555858.
Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al. (December 2013). "Updated clinical classification of pulmonary hypertension". Journal of the American College of Cardiology. 62 (25 Suppl): D34–D41. doi:10.1016/j.jacc.2013.10.029. PMID 24355639.
Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. (ESC Scientific Document Group) (January 2016). "2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)". European Heart Journal. 37 (1): 67–119. doi:10.1093/eurheartj/ehv317. PMID 26320113.
Kolaitis NA, Zamanian RT, de Jesus Perez VA, Badesch DB, Benza RL, Burger CD, et al. (April 2021). "Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry". Annals of the American Thoracic Society. 18 (4): 613–622. doi:10.1513/AnnalsATS.202007-774OC. PMC 8174020. PMID 33064950.
McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. (April 2009). "ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association". Journal of the American College of Cardiology. 53 (17): 1573–1619. doi:10.1016/j.jacc.2009.01.004. PMID 19389575.
Diller GP, Gatzoulis MA (February 2007). "Pulmonary vascular disease in adults with congenital heart disease". Circulation. 115 (8): 1039–50. doi:10.1161/CIRCULATIONAHA.105.592386. PMID 17325254.
Fang JC, DeMarco T, Givertz MM, Borlaug BA, Lewis GD, Rame JE, et al. (September 2012). "World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation". The Journal of Heart and Lung Transplantation. 31 (9): 913–933. doi:10.1016/j.healun.2012.06.002. PMID 22884380.
Simonneau G, Galiè N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, et al. (June 2004). "Clinical classification of pulmonary hypertension". Journal of the American College of Cardiology. 43 (12 Suppl S): 5S–12S. doi:10.1016/j.jacc.2004.02.037. PMID 15194173.
Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. (January 2016). "2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)". European Heart Journal. 37 (1): 67–119. doi:10.1093/eurheartj/ehv317. PMID 26320113.
Rabinovitch M (December 2012). "Molecular pathogenesis of pulmonary arterial hypertension". The Journal of Clinical Investigation. 122 (12): 4306–13. doi:10.1172/JCI60658. PMC 3533531. PMID 23202738.
Hadinnapola C, Bleda M, Haimel M, Screaton N, Swift A, Dorfmüller P, et al. (November 2017). "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension". Circulation. 136 (21): 2022–33. doi:10.1161/CIRCULATIONAHA.117.028351. PMC 5700414. PMID 28972005.
Hassoun, Paul M. (16 December 2021). "Pulmonary Arterial Hypertension". New England Journal of Medicine. 385 (25): 2361–76. doi:10.1056/NEJMra2000348. PMID 34910865.
Jacob AS, Nielsen DH, Gianelly RE (February 1985). "Fatal ventricular fibrillation following verapamil in Wolff-Parkinson-White syndrome with atrial fibrillation". Annals of Emergency Medicine. 14 (2): 159–160. doi:10.1016/j.jacc.2013.10.025. PMC 3970402. PMID 3970402.
Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, et al. (December 2013). "Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology". Journal of the American College of Cardiology. 62 (25 Suppl): D22–D33. doi:10.1016/j.jacc.2013.10.027. PMID 24355638.
Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. (December 2009). "Guidelines for the diagnosis and treatment of pulmonary hypertension". The European Respiratory Journal. 34 (6): 1219–63. doi:10.1183/09031936.00139009. PMID 19749199.
Yuan JX, Rubin LJ (February 2005). "Pathogenesis of pulmonary arterial hypertension: the need for multiple hits". Circulation. 111 (5): 534–8. doi:10.1161/01.CIR.0000156326.48823.55. PMID 15699271.
Tuder RM, Marecki JC, Richter A, Fijalkowska I, Flores S (March 2007). "Pathology of pulmonary hypertension". Clinics in Chest Medicine. 28 (1): 23–42, vii. doi:10.1016/j.ccm.2006.11.010. PMC 1924722. PMID 17338926.
Bordones-Crom A, Patnaik SS, Menon PG, Murali S, Finol E (July 2021). "Morphological Analysis of the Right Ventricular Endocardial Wall in Pulmonary Hypertension". Journal of Biomechanical Engineering. 143 (7). doi:10.1115/1.4050457. PMID 33704381. S2CID 232193407.
Montani D, Price LC, Dorfmuller P, Achouh L, Jaïs X, Yaïci A, et al. (January 2009). "Pulmonary veno-occlusive disease". The European Respiratory Journal. 33 (1): 189–200. doi:10.1183/09031936.00090608. PMID 19118230.
Guazzi M, Galiè N (December 2012). "Pulmonary hypertension in left heart disease". European Respiratory Review. 21 (126): 338–346. doi:10.1183/09059180.00004612. PMC 9487233. PMID 23204122.
Vachiéry JL, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, et al. (December 2013). "Pulmonary hypertension due to left heart diseases". Journal of the American College of Cardiology. 62 (25 Suppl): D100–D108. doi:10.1016/j.jacc.2013.10.033. hdl:11585/534481. PMID 24355634.
Shanks N, Macklin J, Coles S (2009). "Comparison of oral erythromycin ethylsuccinate and clavulanate-potentiated amoxicillin in the treatment of acute respiratory tract infections". Clinical Therapeutics. 11 (6): 812–9. doi:10.1016/j.coph.2009.02.006. PMC 2692823. PMID 2692823.
Sommer N, Dietrich A, Schermuly RT, Ghofrani HA, Gudermann T, Schulz R, et al. (December 2008). "Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms". The European Respiratory Journal. 32 (6): 1639–51. doi:10.1183/09031936.00013908. PMID 19043010.
Stenmark KR, Fagan KA, Frid MG (September 2006). "Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms". Circulation Research. 99 (7): 675–691. doi:10.1161/01.RES.0000243584.45145.3f. PMID 17008597.
McNeil K, Dunning J (September 2007). "Chronic thromboembolic pulmonary hypertension (CTEPH)". Heart. 93 (9): 1152–8. doi:10.1136/hrt.2004.053603. PMC 1955041. PMID 17699182.
Hoeper MM, Mayer E, Simonneau G, Rubin LJ (April 2006). "Chronic thromboembolic pulmonary hypertension". Circulation. 113 (16): 2011–20. doi:10.1161/CIRCULATIONAHA.105.602565. PMID 16636189.
Budhiraja R, Tuder RM, Hassoun PM (January 2004). "Endothelial dysfunction in pulmonary hypertension". Circulation. 109 (2): 159–165. doi:10.1161/01.CIR.0000102381.57477.50. PMID 14734504.
Förstermann U, Münzel T (April 2006). "Endothelial nitric oxide synthase in vascular disease: from marvel to menace". Circulation. 113 (13): 1708–14. doi:10.1161/CIRCULATIONAHA.105.602532. PMID 16585403.
Murad F (November 2006). "Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development". The New England Journal of Medicine. 355 (19): 2003–11. doi:10.1056/NEJMsa063904. PMID 17093251.
Francis SH, Busch JL, Corbin JD, Sibley D (September 2010). "cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action". Pharmacological Reviews. 62 (3): 525–563. doi:10.1124/pr.110.002907. PMC 2964902. PMID 20716671.
Ghofrani HA, Pepke-Zaba J, Barbera JA, Channick R, Keogh AM, Gomez-Sanchez MA, et al. (June 2004). "Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension". Journal of the American College of Cardiology. 43 (12 Suppl S): 68S–72S. doi:10.1016/j.jacc.2004.02.031. PMID 15194181.
McLaughlin VV, McGoon MD (September 2006). "Pulmonary arterial hypertension". Circulation. 114 (13): 1417–31. doi:10.1161/CIRCULATIONAHA.104.503540. PMID 17000921.
Fonseca C, Abraham D, Renzoni EA (January 2011). "Endothelin in pulmonary fibrosis". American Journal of Respiratory Cell and Molecular Biology. 44 (1): 1–10. doi:10.1165/rcmb.2009-0388TR. PMID 20448055.
Wood SF (January 1986). "Astemizole and terfenadine compared in hay fever". The Practitioner. 230 (1411): 41–44. doi:10.1161/CIRCULATIONAHA.108.847707. PMC 2869481. PMID 2869481.
Gomberg-Maitland M, Olschewski H (April 2008). "Prostacyclin therapies for the treatment of pulmonary arterial hypertension". The European Respiratory Journal. 31 (4): 891–901. doi:10.1183/09031936.00097107. PMID 18378784.
Lenfant M (2013). "[Dihydrostreptomycin fixation on the ribosomes of E. coli]". Biochimie. 54 (2): 283–5. doi:10.1016/j.jacc.2013.10.026. PMC 4117578. PMID 4117578.
Lawrie A (December 2014). "The role of the osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the pathogenesis of pulmonary arterial hypertension". Vascular Pharmacology. 63 (3): 114–7. doi:10.1016/j.vph.2014.10.002. PMID 25446166.
Braithwaite AT, Marriott HM, Lawrie A (2018). "Divergent Roles for TRAIL in Lung Diseases". Frontiers in Medicine. 5: 212. doi:10.3389/fmed.2018.00212. PMC 6072839. PMID 30101145.
Ranchoux B, Meloche J, Paulin R, Boucherat O, Provencher S, Bonnet S (June 2016). "DNA Damage and Pulmonary Hypertension". Int J Mol Sci. 17 (6): 990. doi:10.3390/ijms17060990. PMC 4926518. PMID 27338373.
Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, et al. (December 2013). "Definitions and diagnosis of pulmonary hypertension". Journal of the American College of Cardiology. 62 (25 Suppl): D42–D50. doi:10.1016/j.jacc.2013.10.032. PMID 24355641.
Taleb M, Khuder S, Tinkel J, Khouri SJ (March 2013). "The diagnostic accuracy of Doppler echocardiography in assessment of pulmonary artery systolic pressure: a meta-analysis". Echocardiography. 30 (3): 258–265. doi:10.1111/echo.12061. PMID 23227919. S2CID 7460778.
Bossone E, D'Andrea A, D'Alto M, Citro R, Argiento P, Ferrara F, et al. (January 2013). "Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis". Journal of the American Society of Echocardiography. 26 (1): 1–14. doi:10.1016/j.echo.2012.10.009. PMID 23140849.
Piskin S, Patnaik SS, Han D, Bordones AD, Murali S, Finol EA (March 2020). "A canonical correlation analysis of the relationship between clinical attributes and patient-specific hemodynamic indices in adult pulmonary hypertension". Medical Engineering & Physics. 77: 1–9. doi:10.1016/j.medengphy.2020.01.006. PMC 7069525. PMID 32007361.
Pillalamarri NR, Piskin S, Patnaik SS, Murali S, Finol EA (December 2021). "Patient-Specific Computational Analysis of Hemodynamics in Adult Pulmonary Hypertension". Annals of Biomedical Engineering. 49 (12): 3465–80. doi:10.1007/s10439-021-02884-y. PMC 8684831. PMID 34799807.
American College of Chest Physicians; American Thoracic Society (September 2013), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American College of Chest Physicians and American Thoracic Society, archived from the original on 3 November 2013, retrieved 6 January 2013, which cites
- McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. (April 2009). "ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association". Circulation. 119 (16): 2250–94. doi:10.1161/CIRCULATIONAHA.109.192230. PMID 19332472.
- Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, Gaine S (June 2004). "Diagnosis and differential assessment of pulmonary arterial hypertension". Journal of the American College of Cardiology. 43 (12 Suppl S): 40S–47S. doi:10.1016/j.jacc.2004.02.032. PMID 15194177.
- Sitbon O, Humbert M, Jaïs X, Ioos V, Hamid AM, Provencher S, et al. (June 2005). "Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension". Circulation. 111 (23): 3105–11. doi:10.1161/CIRCULATIONAHA.104.488486. PMID 15939821.
- Torres F (October 2007). "Systematic review of randomised, double-blind clinical trials of oral agents conducted in patients with pulmonary arterial hypertension". International Journal of Clinical Practice. 61 (10): 1756–65. doi:10.1111/j.1742-1241.2007.01545.x. PMID 17877662. S2CID 1191543.
- Morris NR, Kermeen FD, Jones AW, Lee JY, Holland AE, et al. (Cochrane Airways Group) (March 2023). "Exercise-based rehabilitation programmes for pulmonary hypertension". The Cochrane Database of Systematic Reviews. 2023 (3): CD011285. doi:10.1002/14651858.CD011285.pub3. PMC 10032353. PMID 36947725.
- Raja SG, Raja SM (November 2011). "Treating pulmonary arterial hypertension: current treatments and future prospects". Therapeutic Advances in Chronic Disease. 2 (6): 359–370. doi:10.1177/2040622311420773. PMC 3513893. PMID 23251761.
- Safdar Z (June 2011). "Treatment of pulmonary arterial hypertension: the role of prostacyclin and prostaglandin analogs". Respiratory Medicine. 105 (6): 818–827. doi:10.1016/j.rmed.2010.12.018. PMID 21273054.
- Liu C, Chen J, Gao Y, Deng B, Liu K, et al. (Cochrane Airways Group) (March 2021). "Endothelin receptor antagonists for pulmonary arterial hypertension". The Cochrane Database of Systematic Reviews. 2021 (3): CD004434. doi:10.1002/14651858.CD004434.pub6. PMC 8094512. PMID 33765691.
- Duarte JD, Hanson RL, Machado RF (May 2013). "Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomics". Future Cardiology. 9 (3): 335–349. doi:10.2217/fca.13.6. PMC 3864092. PMID 23668740.
- Forgue ST, Patterson BE, Bedding AW, Payne CD, Phillips DL, Wrishko RE, Mitchell MI (March 2006). "Tadalafil pharmacokinetics in healthy subjects". British Journal of Clinical Pharmacology. 61 (3): 280–8. doi:10.1111/j.1365-2125.2005.02553.x. PMC 1885023. PMID 16487221.
- Arif SA, Poon H (August 2011). "Tadalafil: a long-acting phosphodiesterase-5 inhibitor for the treatment of pulmonary arterial hypertension". Clin Ther. 33 (8): 993–1004. doi:10.1016/j.clinthera.2011.06.008. PMID 21762988.
- Galiè N, Brundage BH, Ghofrani HA, Oudiz RJ, Simonneau G, Safdar Z, et al. (June 2009). "Tadalafil therapy for pulmonary arterial hypertension". Circulation. 119 (22): 2894–2903. doi:10.1161/circulationaha.108.839274. PMID 19470885.
- Lasker GF, Maley JH, Pankey EA, Kadowitz PJ (April 2011). "Targeting soluble guanylate cyclase for the treatment of pulmonary hypertension". Expert Review of Respiratory Medicine. 5 (2): 153–161. doi:10.1586/ers.11.9. PMC 3108035. PMID 21510726.
- George MP, Champion HC, Pilewski JM (2011). "Lung transplantation for pulmonary hypertension". Pulmonary Circulation. 1 (2): 182–191. doi:10.4103/2045-8932.83455. PMC 3198646. PMID 22034605.
- Cerveri I, D'Armini AM, Viganò M (April 2003). "Pulmonary thromboendarterectomy almost 50 years after the first surgical attempts". Heart. 89 (4): 369–370. doi:10.1136/heart.89.4.369. PMC 1769265. PMID 12639858.
- Mouratoglou SA, Bayoumy AA, Noordegraaf AV (2021). "Prediction Models and Scores in Pulmonary Hypertension: A Review". Current Pharmaceutical Design. 27 (10): 1266–76. doi:10.2174/1381612824999201105163437. PMID 33155897. S2CID 226272078.
- McLaughlin VV, Sitbon O, Badesch DB, Barst RJ, Black C, Galiè N, et al. (February 2005). "Survival with first-line bosentan in patients with primary pulmonary hypertension". The European Respiratory Journal. 25 (2): 244–9. doi:10.1183/09031936.05.00054804. PMID 15684287.
- Benza RL, Miller DP, Barst RJ, Badesch DB, Frost AE, McGoon MD (August 2012). "An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry". Chest. 142 (2): 448–456. doi:10.1378/chest.11-1460. PMID 22281797.
- York M, Farber HW (November 2011). "Pulmonary hypertension: screening and evaluation in scleroderma". Current Opinion in Rheumatology. 23 (6): 536–544. doi:10.1097/BOR.0b013e32834ba6a7. PMID 21934501. S2CID 19528958.
- Mittoo S, Fell CD (April 2014). "Pulmonary manifestations of systemic lupus erythematosus". Seminars in Respiratory and Critical Care Medicine. 35 (2). MedScape: 249–254. doi:10.1055/s-0034-1371537. PMID 24668539. S2CID 24654448. Archived from the original on 26 October 2015. Retrieved 31 December 2015.
- Minai OA, Chaouat A, Adnot S (June 2010). "Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective". Chest. 137 (6 Suppl): 39S–51S. doi:10.1378/chest.10-0087. PMID 20522579.
- Balachandran JS, Masa JF, Mokhlesi B (September 2014). "Obesity Hypoventilation Syndrome Epidemiology and Diagnosis". Sleep Medicine Clinics. 9 (3): 341–7. doi:10.1016/j.jsmc.2014.05.007. PMC 4210766. PMID 25360072.
- Reynolds PN (February 2011). "Gene therapy for pulmonary hypertension: prospects and challenges". Expert Opinion on Biological Therapy. 11 (2): 133–143. doi:10.1517/14712598.2011.542139. PMID 21219232. S2CID 23641857.

fda.gov

accessdata.fda.gov

"Drugs@FDA: FDA-Approved Drugs".
"Approval Letter: Opsynvi (macitentan and tadalafil)" (PDF). U.S. Food and Drug Administration.

gilead.com

"U.S. Food and Drug Administration Approves Gilead's Letairis Treatment of Pulmonary Arterial Hypertension" (Press release). Gilead Sciences. 2007-06-15. Archived from the original on 2007-09-27. Retrieved 2007-06-16.

handle.net

hdl.handle.net

Vachiéry JL, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, et al. (December 2013). "Pulmonary hypertension due to left heart diseases". Journal of the American College of Cardiology. 62 (25 Suppl): D100–D108. doi:10.1016/j.jacc.2013.10.033. hdl:11585/534481. PMID 24355634.

huffingtonpost.com

Insdorf A (November 10, 2013). "The Challenges of Chloe Temtchine". The Huffington Post. Archived from the original on September 18, 2016.

jnj.com

"Opsynvi (macitentan and tadalafil) Becomes the First and Only Health Canada-Approved Once Daily Fixed Dose Combination Treatment for Patients with Pulmonary Arterial Hypertension (PAH)". Johnson & Johnson (Press release). 15 October 2021. Retrieved 25 March 2024.
"U.S. FDA Approves Opsynvi (macitentan and tadalafil) as the First and Only Once-Daily Single-Tablet Combination Therapy for Patients with Pulmonary Arterial Hypertension (PAH)". Johnson & Johnson (Press release). 22 March 2024. Retrieved 25 March 2024.

latimes.com

articles.latimes.com

Folkart BA (21 June 1990). "Ina Balin, 52; Movie and TV Actress Sought Lung Implant". Los Angeles Times. Archived from the original on 11 September 2016. Retrieved 27 September 2016.

lung.org

"Learn About Pulmonary Arterial Hypertension". PAH. American Lung Association. Retrieved 2023-08-01.

medlineplus.gov

"Swan-Ganz — right heart catheterization". Medical Encyclopedia. MedlinePlus, National Library of Medicine. 2022.

medscape.com

emedicine.medscape.com

"Primary Pulmonary Hypertension Clinical Presentation: History, Physical Examination, Complications". emedicine.medscape.com. Archived from the original on 2015-11-01. Retrieved 2015-12-30.
Oudiz RJ (6 February 2023). "Idiopathic Pulmonary Arterial Hypertension: Practice Essentials, Background, Pathophysiology". Medscape Reference.

medscape.com

Nannini C. "Lung Disease in Rheumatoid Arthritis". MedScape.com. MedScape. Archived from the original on 8 February 2016. Retrieved 31 December 2015.
Mittoo S, Fell CD (April 2014). "Pulmonary manifestations of systemic lupus erythematosus". Seminars in Respiratory and Critical Care Medicine. 35 (2). MedScape: 249–254. doi:10.1055/s-0034-1371537. PMID 24668539. S2CID 24654448. Archived from the original on 26 October 2015. Retrieved 31 December 2015.

merck.com

"FDA Approves Merck's Winrevair (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1)" (Press release). Merck. 27 March 2024. Retrieved 27 March 2024.

news-medical.net

"FDA approves Adcirca (tadalafil) tablets for pulmonary arterial hypertension" (Press release). 2009-05-26. Archived from the original on 2010-12-03. Retrieved 2010-12-06.

nih.gov

pubmed.ncbi.nlm.nih.gov

Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RM, Brida M, et al. (October 2022). "2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension". European Heart Journal. 43 (38): 3618–3731. doi:10.1093/eurheartj/ehac237. PMID 36017548.
Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, et al. (June 2009). "Updated clinical classification of pulmonary hypertension". Journal of the American College of Cardiology. 54 (1 Suppl): S43–S54. doi:10.1016/j.jacc.2009.04.012. PMID 19555858.
Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al. (December 2013). "Updated clinical classification of pulmonary hypertension". Journal of the American College of Cardiology. 62 (25 Suppl): D34–D41. doi:10.1016/j.jacc.2013.10.029. PMID 24355639.
Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. (ESC Scientific Document Group) (January 2016). "2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)". European Heart Journal. 37 (1): 67–119. doi:10.1093/eurheartj/ehv317. PMID 26320113.
Kolaitis NA, Zamanian RT, de Jesus Perez VA, Badesch DB, Benza RL, Burger CD, et al. (April 2021). "Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry". Annals of the American Thoracic Society. 18 (4): 613–622. doi:10.1513/AnnalsATS.202007-774OC. PMC 8174020. PMID 33064950.
McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. (April 2009). "ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association". Journal of the American College of Cardiology. 53 (17): 1573–1619. doi:10.1016/j.jacc.2009.01.004. PMID 19389575.
Diller GP, Gatzoulis MA (February 2007). "Pulmonary vascular disease in adults with congenital heart disease". Circulation. 115 (8): 1039–50. doi:10.1161/CIRCULATIONAHA.105.592386. PMID 17325254.
Fang JC, DeMarco T, Givertz MM, Borlaug BA, Lewis GD, Rame JE, et al. (September 2012). "World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation". The Journal of Heart and Lung Transplantation. 31 (9): 913–933. doi:10.1016/j.healun.2012.06.002. PMID 22884380.
Simonneau G, Galiè N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, et al. (June 2004). "Clinical classification of pulmonary hypertension". Journal of the American College of Cardiology. 43 (12 Suppl S): 5S–12S. doi:10.1016/j.jacc.2004.02.037. PMID 15194173.
Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. (January 2016). "2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)". European Heart Journal. 37 (1): 67–119. doi:10.1093/eurheartj/ehv317. PMID 26320113.
Rabinovitch M (December 2012). "Molecular pathogenesis of pulmonary arterial hypertension". The Journal of Clinical Investigation. 122 (12): 4306–13. doi:10.1172/JCI60658. PMC 3533531. PMID 23202738.
Hadinnapola C, Bleda M, Haimel M, Screaton N, Swift A, Dorfmüller P, et al. (November 2017). "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension". Circulation. 136 (21): 2022–33. doi:10.1161/CIRCULATIONAHA.117.028351. PMC 5700414. PMID 28972005.
Hassoun, Paul M. (16 December 2021). "Pulmonary Arterial Hypertension". New England Journal of Medicine. 385 (25): 2361–76. doi:10.1056/NEJMra2000348. PMID 34910865.
Jacob AS, Nielsen DH, Gianelly RE (February 1985). "Fatal ventricular fibrillation following verapamil in Wolff-Parkinson-White syndrome with atrial fibrillation". Annals of Emergency Medicine. 14 (2): 159–160. doi:10.1016/j.jacc.2013.10.025. PMC 3970402. PMID 3970402.
Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, et al. (December 2013). "Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology". Journal of the American College of Cardiology. 62 (25 Suppl): D22–D33. doi:10.1016/j.jacc.2013.10.027. PMID 24355638.
Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. (December 2009). "Guidelines for the diagnosis and treatment of pulmonary hypertension". The European Respiratory Journal. 34 (6): 1219–63. doi:10.1183/09031936.00139009. PMID 19749199.
Yuan JX, Rubin LJ (February 2005). "Pathogenesis of pulmonary arterial hypertension: the need for multiple hits". Circulation. 111 (5): 534–8. doi:10.1161/01.CIR.0000156326.48823.55. PMID 15699271.
Tuder RM, Marecki JC, Richter A, Fijalkowska I, Flores S (March 2007). "Pathology of pulmonary hypertension". Clinics in Chest Medicine. 28 (1): 23–42, vii. doi:10.1016/j.ccm.2006.11.010. PMC 1924722. PMID 17338926.
Bordones-Crom A, Patnaik SS, Menon PG, Murali S, Finol E (July 2021). "Morphological Analysis of the Right Ventricular Endocardial Wall in Pulmonary Hypertension". Journal of Biomechanical Engineering. 143 (7). doi:10.1115/1.4050457. PMID 33704381. S2CID 232193407.
Montani D, Price LC, Dorfmuller P, Achouh L, Jaïs X, Yaïci A, et al. (January 2009). "Pulmonary veno-occlusive disease". The European Respiratory Journal. 33 (1): 189–200. doi:10.1183/09031936.00090608. PMID 19118230.
Guazzi M, Galiè N (December 2012). "Pulmonary hypertension in left heart disease". European Respiratory Review. 21 (126): 338–346. doi:10.1183/09059180.00004612. PMC 9487233. PMID 23204122.
Vachiéry JL, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, et al. (December 2013). "Pulmonary hypertension due to left heart diseases". Journal of the American College of Cardiology. 62 (25 Suppl): D100–D108. doi:10.1016/j.jacc.2013.10.033. hdl:11585/534481. PMID 24355634.
Shanks N, Macklin J, Coles S (2009). "Comparison of oral erythromycin ethylsuccinate and clavulanate-potentiated amoxicillin in the treatment of acute respiratory tract infections". Clinical Therapeutics. 11 (6): 812–9. doi:10.1016/j.coph.2009.02.006. PMC 2692823. PMID 2692823.
Sommer N, Dietrich A, Schermuly RT, Ghofrani HA, Gudermann T, Schulz R, et al. (December 2008). "Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms". The European Respiratory Journal. 32 (6): 1639–51. doi:10.1183/09031936.00013908. PMID 19043010.
Stenmark KR, Fagan KA, Frid MG (September 2006). "Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms". Circulation Research. 99 (7): 675–691. doi:10.1161/01.RES.0000243584.45145.3f. PMID 17008597.
McNeil K, Dunning J (September 2007). "Chronic thromboembolic pulmonary hypertension (CTEPH)". Heart. 93 (9): 1152–8. doi:10.1136/hrt.2004.053603. PMC 1955041. PMID 17699182.
Hoeper MM, Mayer E, Simonneau G, Rubin LJ (April 2006). "Chronic thromboembolic pulmonary hypertension". Circulation. 113 (16): 2011–20. doi:10.1161/CIRCULATIONAHA.105.602565. PMID 16636189.
Budhiraja R, Tuder RM, Hassoun PM (January 2004). "Endothelial dysfunction in pulmonary hypertension". Circulation. 109 (2): 159–165. doi:10.1161/01.CIR.0000102381.57477.50. PMID 14734504.
Förstermann U, Münzel T (April 2006). "Endothelial nitric oxide synthase in vascular disease: from marvel to menace". Circulation. 113 (13): 1708–14. doi:10.1161/CIRCULATIONAHA.105.602532. PMID 16585403.
Murad F (November 2006). "Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development". The New England Journal of Medicine. 355 (19): 2003–11. doi:10.1056/NEJMsa063904. PMID 17093251.
Francis SH, Busch JL, Corbin JD, Sibley D (September 2010). "cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action". Pharmacological Reviews. 62 (3): 525–563. doi:10.1124/pr.110.002907. PMC 2964902. PMID 20716671.
Zelia OP, Kovalenko FP (2011). "Comparative efficiency of infecting laboratory animals via intravenous and subcutaneous administration of Schistosoma mansoni cercaria]". Parazitologiia. 20 (6): 461–5. PMID 3103045.
Ghofrani HA, Pepke-Zaba J, Barbera JA, Channick R, Keogh AM, Gomez-Sanchez MA, et al. (June 2004). "Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension". Journal of the American College of Cardiology. 43 (12 Suppl S): 68S–72S. doi:10.1016/j.jacc.2004.02.031. PMID 15194181.
McLaughlin VV, McGoon MD (September 2006). "Pulmonary arterial hypertension". Circulation. 114 (13): 1417–31. doi:10.1161/CIRCULATIONAHA.104.503540. PMID 17000921.
Fonseca C, Abraham D, Renzoni EA (January 2011). "Endothelin in pulmonary fibrosis". American Journal of Respiratory Cell and Molecular Biology. 44 (1): 1–10. doi:10.1165/rcmb.2009-0388TR. PMID 20448055.
Wood SF (January 1986). "Astemizole and terfenadine compared in hay fever". The Practitioner. 230 (1411): 41–44. doi:10.1161/CIRCULATIONAHA.108.847707. PMC 2869481. PMID 2869481.
Gomberg-Maitland M, Olschewski H (April 2008). "Prostacyclin therapies for the treatment of pulmonary arterial hypertension". The European Respiratory Journal. 31 (4): 891–901. doi:10.1183/09031936.00097107. PMID 18378784.
Lenfant M (2013). "[Dihydrostreptomycin fixation on the ribosomes of E. coli]". Biochimie. 54 (2): 283–5. doi:10.1016/j.jacc.2013.10.026. PMC 4117578. PMID 4117578.
Lawrie A (December 2014). "The role of the osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the pathogenesis of pulmonary arterial hypertension". Vascular Pharmacology. 63 (3): 114–7. doi:10.1016/j.vph.2014.10.002. PMID 25446166.
Braithwaite AT, Marriott HM, Lawrie A (2018). "Divergent Roles for TRAIL in Lung Diseases". Frontiers in Medicine. 5: 212. doi:10.3389/fmed.2018.00212. PMC 6072839. PMID 30101145.
Ranchoux B, Meloche J, Paulin R, Boucherat O, Provencher S, Bonnet S (June 2016). "DNA Damage and Pulmonary Hypertension". Int J Mol Sci. 17 (6): 990. doi:10.3390/ijms17060990. PMC 4926518. PMID 27338373.
Austin ED, Loyd JE, Phillips JA (January 1993). "Heritable Pulmonary Arterial Hypertension Overview". In Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJ, Bird TD, Fong C, Mefford HC (eds.). GeneReviews. Seattle (WA): University of Washington, Seattle. PMID 20301658. NBK1485.
Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, et al. (December 2013). "Definitions and diagnosis of pulmonary hypertension". Journal of the American College of Cardiology. 62 (25 Suppl): D42–D50. doi:10.1016/j.jacc.2013.10.032. PMID 24355641.
Taleb M, Khuder S, Tinkel J, Khouri SJ (March 2013). "The diagnostic accuracy of Doppler echocardiography in assessment of pulmonary artery systolic pressure: a meta-analysis". Echocardiography. 30 (3): 258–265. doi:10.1111/echo.12061. PMID 23227919. S2CID 7460778.
Bossone E, D'Andrea A, D'Alto M, Citro R, Argiento P, Ferrara F, et al. (January 2013). "Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis". Journal of the American Society of Echocardiography. 26 (1): 1–14. doi:10.1016/j.echo.2012.10.009. PMID 23140849.
Piskin S, Patnaik SS, Han D, Bordones AD, Murali S, Finol EA (March 2020). "A canonical correlation analysis of the relationship between clinical attributes and patient-specific hemodynamic indices in adult pulmonary hypertension". Medical Engineering & Physics. 77: 1–9. doi:10.1016/j.medengphy.2020.01.006. PMC 7069525. PMID 32007361.
Pillalamarri NR, Piskin S, Patnaik SS, Murali S, Finol EA (December 2021). "Patient-Specific Computational Analysis of Hemodynamics in Adult Pulmonary Hypertension". Annals of Biomedical Engineering. 49 (12): 3465–80. doi:10.1007/s10439-021-02884-y. PMC 8684831. PMID 34799807.
American College of Chest Physicians; American Thoracic Society (September 2013), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American College of Chest Physicians and American Thoracic Society, archived from the original on 3 November 2013, retrieved 6 January 2013, which cites
- McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. (April 2009). "ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association". Circulation. 119 (16): 2250–94. doi:10.1161/CIRCULATIONAHA.109.192230. PMID 19332472.
- Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, Gaine S (June 2004). "Diagnosis and differential assessment of pulmonary arterial hypertension". Journal of the American College of Cardiology. 43 (12 Suppl S): 40S–47S. doi:10.1016/j.jacc.2004.02.032. PMID 15194177.
- Sitbon O, Humbert M, Jaïs X, Ioos V, Hamid AM, Provencher S, et al. (June 2005). "Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension". Circulation. 111 (23): 3105–11. doi:10.1161/CIRCULATIONAHA.104.488486. PMID 15939821.
- Torres F (October 2007). "Systematic review of randomised, double-blind clinical trials of oral agents conducted in patients with pulmonary arterial hypertension". International Journal of Clinical Practice. 61 (10): 1756–65. doi:10.1111/j.1742-1241.2007.01545.x. PMID 17877662. S2CID 1191543.
- Morris NR, Kermeen FD, Jones AW, Lee JY, Holland AE, et al. (Cochrane Airways Group) (March 2023). "Exercise-based rehabilitation programmes for pulmonary hypertension". The Cochrane Database of Systematic Reviews. 2023 (3): CD011285. doi:10.1002/14651858.CD011285.pub3. PMC 10032353. PMID 36947725.
- Raja SG, Raja SM (November 2011). "Treating pulmonary arterial hypertension: current treatments and future prospects". Therapeutic Advances in Chronic Disease. 2 (6): 359–370. doi:10.1177/2040622311420773. PMC 3513893. PMID 23251761.
- Safdar Z (June 2011). "Treatment of pulmonary arterial hypertension: the role of prostacyclin and prostaglandin analogs". Respiratory Medicine. 105 (6): 818–827. doi:10.1016/j.rmed.2010.12.018. PMID 21273054.
- Liu C, Chen J, Gao Y, Deng B, Liu K, et al. (Cochrane Airways Group) (March 2021). "Endothelin receptor antagonists for pulmonary arterial hypertension". The Cochrane Database of Systematic Reviews. 2021 (3): CD004434. doi:10.1002/14651858.CD004434.pub6. PMC 8094512. PMID 33765691.
- Duarte JD, Hanson RL, Machado RF (May 2013). "Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomics". Future Cardiology. 9 (3): 335–349. doi:10.2217/fca.13.6. PMC 3864092. PMID 23668740.
- Forgue ST, Patterson BE, Bedding AW, Payne CD, Phillips DL, Wrishko RE, Mitchell MI (March 2006). "Tadalafil pharmacokinetics in healthy subjects". British Journal of Clinical Pharmacology. 61 (3): 280–8. doi:10.1111/j.1365-2125.2005.02553.x. PMC 1885023. PMID 16487221.
- Arif SA, Poon H (August 2011). "Tadalafil: a long-acting phosphodiesterase-5 inhibitor for the treatment of pulmonary arterial hypertension". Clin Ther. 33 (8): 993–1004. doi:10.1016/j.clinthera.2011.06.008. PMID 21762988.
- Galiè N, Brundage BH, Ghofrani HA, Oudiz RJ, Simonneau G, Safdar Z, et al. (June 2009). "Tadalafil therapy for pulmonary arterial hypertension". Circulation. 119 (22): 2894–2903. doi:10.1161/circulationaha.108.839274. PMID 19470885.
- Lasker GF, Maley JH, Pankey EA, Kadowitz PJ (April 2011). "Targeting soluble guanylate cyclase for the treatment of pulmonary hypertension". Expert Review of Respiratory Medicine. 5 (2): 153–161. doi:10.1586/ers.11.9. PMC 3108035. PMID 21510726.
- George MP, Champion HC, Pilewski JM (2011). "Lung transplantation for pulmonary hypertension". Pulmonary Circulation. 1 (2): 182–191. doi:10.4103/2045-8932.83455. PMC 3198646. PMID 22034605.
- Cerveri I, D'Armini AM, Viganò M (April 2003). "Pulmonary thromboendarterectomy almost 50 years after the first surgical attempts". Heart. 89 (4): 369–370. doi:10.1136/heart.89.4.369. PMC 1769265. PMID 12639858.
- Mouratoglou SA, Bayoumy AA, Noordegraaf AV (2021). "Prediction Models and Scores in Pulmonary Hypertension: A Review". Current Pharmaceutical Design. 27 (10): 1266–76. doi:10.2174/1381612824999201105163437. PMID 33155897. S2CID 226272078.
- McLaughlin VV, Sitbon O, Badesch DB, Barst RJ, Black C, Galiè N, et al. (February 2005). "Survival with first-line bosentan in patients with primary pulmonary hypertension". The European Respiratory Journal. 25 (2): 244–9. doi:10.1183/09031936.05.00054804. PMID 15684287.
- Benza RL, Miller DP, Barst RJ, Badesch DB, Frost AE, McGoon MD (August 2012). "An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry". Chest. 142 (2): 448–456. doi:10.1378/chest.11-1460. PMID 22281797.
- York M, Farber HW (November 2011). "Pulmonary hypertension: screening and evaluation in scleroderma". Current Opinion in Rheumatology. 23 (6): 536–544. doi:10.1097/BOR.0b013e32834ba6a7. PMID 21934501. S2CID 19528958.
- Mittoo S, Fell CD (April 2014). "Pulmonary manifestations of systemic lupus erythematosus". Seminars in Respiratory and Critical Care Medicine. 35 (2). MedScape: 249–254. doi:10.1055/s-0034-1371537. PMID 24668539. S2CID 24654448. Archived from the original on 26 October 2015. Retrieved 31 December 2015.
- Lee MT, Rosenzweig EB, Cairo MS (August 2007). "Pulmonary hypertension in sickle cell disease". Clinical Advances in Hematology & Oncology. 5 (8): 645–53, 585. PMID 17982405.
- Minai OA, Chaouat A, Adnot S (June 2010). "Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective". Chest. 137 (6 Suppl): 39S–51S. doi:10.1378/chest.10-0087. PMID 20522579.
- Balachandran JS, Masa JF, Mokhlesi B (September 2014). "Obesity Hypoventilation Syndrome Epidemiology and Diagnosis". Sleep Medicine Clinics. 9 (3): 341–7. doi:10.1016/j.jsmc.2014.05.007. PMC 4210766. PMID 25360072.
- Reynolds PN (February 2011). "Gene therapy for pulmonary hypertension: prospects and challenges". Expert Opinion on Biological Therapy. 11 (2): 133–143. doi:10.1517/14712598.2011.542139. PMID 21219232. S2CID 23641857.
ncbi.nlm.nih.gov
- Kolaitis NA, Zamanian RT, de Jesus Perez VA, Badesch DB, Benza RL, Burger CD, et al. (April 2021). "Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry". Annals of the American Thoracic Society. 18 (4): 613–622. doi:10.1513/AnnalsATS.202007-774OC. PMC 8174020. PMID 33064950.
- Rabinovitch M (December 2012). "Molecular pathogenesis of pulmonary arterial hypertension". The Journal of Clinical Investigation. 122 (12): 4306–13. doi:10.1172/JCI60658. PMC 3533531. PMID 23202738.
- Hadinnapola C, Bleda M, Haimel M, Screaton N, Swift A, Dorfmüller P, et al. (November 2017). "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension". Circulation. 136 (21): 2022–33. doi:10.1161/CIRCULATIONAHA.117.028351. PMC 5700414. PMID 28972005.
- Jacob AS, Nielsen DH, Gianelly RE (February 1985). "Fatal ventricular fibrillation following verapamil in Wolff-Parkinson-White syndrome with atrial fibrillation". Annals of Emergency Medicine. 14 (2): 159–160. doi:10.1016/j.jacc.2013.10.025. PMC 3970402. PMID 3970402.
- Tuder RM, Marecki JC, Richter A, Fijalkowska I, Flores S (March 2007). "Pathology of pulmonary hypertension". Clinics in Chest Medicine. 28 (1): 23–42, vii. doi:10.1016/j.ccm.2006.11.010. PMC 1924722. PMID 17338926.
- Guazzi M, Galiè N (December 2012). "Pulmonary hypertension in left heart disease". European Respiratory Review. 21 (126): 338–346. doi:10.1183/09059180.00004612. PMC 9487233. PMID 23204122.
- Shanks N, Macklin J, Coles S (2009). "Comparison of oral erythromycin ethylsuccinate and clavulanate-potentiated amoxicillin in the treatment of acute respiratory tract infections". Clinical Therapeutics. 11 (6): 812–9. doi:10.1016/j.coph.2009.02.006. PMC 2692823. PMID 2692823.
- McNeil K, Dunning J (September 2007). "Chronic thromboembolic pulmonary hypertension (CTEPH)". Heart. 93 (9): 1152–8. doi:10.1136/hrt.2004.053603. PMC 1955041. PMID 17699182.
- Francis SH, Busch JL, Corbin JD, Sibley D (September 2010). "cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action". Pharmacological Reviews. 62 (3): 525–563. doi:10.1124/pr.110.002907. PMC 2964902. PMID 20716671.
- Wood SF (January 1986). "Astemizole and terfenadine compared in hay fever". The Practitioner. 230 (1411): 41–44. doi:10.1161/CIRCULATIONAHA.108.847707. PMC 2869481. PMID 2869481.
- Lenfant M (2013). "[Dihydrostreptomycin fixation on the ribosomes of E. coli]". Biochimie. 54 (2): 283–5. doi:10.1016/j.jacc.2013.10.026. PMC 4117578. PMID 4117578.
- Braithwaite AT, Marriott HM, Lawrie A (2018). "Divergent Roles for TRAIL in Lung Diseases". Frontiers in Medicine. 5: 212. doi:10.3389/fmed.2018.00212. PMC 6072839. PMID 30101145.
- Ranchoux B, Meloche J, Paulin R, Boucherat O, Provencher S, Bonnet S (June 2016). "DNA Damage and Pulmonary Hypertension". Int J Mol Sci. 17 (6): 990. doi:10.3390/ijms17060990. PMC 4926518. PMID 27338373.
- Austin ED, Loyd JE, Phillips JA (January 1993). "Heritable Pulmonary Arterial Hypertension Overview". In Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJ, Bird TD, Fong C, Mefford HC (eds.). GeneReviews. Seattle (WA): University of Washington, Seattle. PMID 20301658. NBK1485.
- Piskin S, Patnaik SS, Han D, Bordones AD, Murali S, Finol EA (March 2020). "A canonical correlation analysis of the relationship between clinical attributes and patient-specific hemodynamic indices in adult pulmonary hypertension". Medical Engineering & Physics. 77: 1–9. doi:10.1016/j.medengphy.2020.01.006. PMC 7069525. PMID 32007361.
- Pillalamarri NR, Piskin S, Patnaik SS, Murali S, Finol EA (December 2021). "Patient-Specific Computational Analysis of Hemodynamics in Adult Pulmonary Hypertension". Annals of Biomedical Engineering. 49 (12): 3465–80. doi:10.1007/s10439-021-02884-y. PMC 8684831. PMID 34799807.
- Morris NR, Kermeen FD, Jones AW, Lee JY, Holland AE, et al. (Cochrane Airways Group) (March 2023). "Exercise-based rehabilitation programmes for pulmonary hypertension". The Cochrane Database of Systematic Reviews. 2023 (3): CD011285. doi:10.1002/14651858.CD011285.pub3. PMC 10032353. PMID 36947725.
- Raja SG, Raja SM (November 2011). "Treating pulmonary arterial hypertension: current treatments and future prospects". Therapeutic Advances in Chronic Disease. 2 (6): 359–370. doi:10.1177/2040622311420773. PMC 3513893. PMID 23251761.
- Liu C, Chen J, Gao Y, Deng B, Liu K, et al. (Cochrane Airways Group) (March 2021). "Endothelin receptor antagonists for pulmonary arterial hypertension". The Cochrane Database of Systematic Reviews. 2021 (3): CD004434. doi:10.1002/14651858.CD004434.pub6. PMC 8094512. PMID 33765691.
- Duarte JD, Hanson RL, Machado RF (May 2013). "Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomics". Future Cardiology. 9 (3): 335–349. doi:10.2217/fca.13.6. PMC 3864092. PMID 23668740.
- Forgue ST, Patterson BE, Bedding AW, Payne CD, Phillips DL, Wrishko RE, Mitchell MI (March 2006). "Tadalafil pharmacokinetics in healthy subjects". British Journal of Clinical Pharmacology. 61 (3): 280–8. doi:10.1111/j.1365-2125.2005.02553.x. PMC 1885023. PMID 16487221.
- Lasker GF, Maley JH, Pankey EA, Kadowitz PJ (April 2011). "Targeting soluble guanylate cyclase for the treatment of pulmonary hypertension". Expert Review of Respiratory Medicine. 5 (2): 153–161. doi:10.1586/ers.11.9. PMC 3108035. PMID 21510726.
- George MP, Champion HC, Pilewski JM (2011). "Lung transplantation for pulmonary hypertension". Pulmonary Circulation. 1 (2): 182–191. doi:10.4103/2045-8932.83455. PMC 3198646. PMID 22034605.
- Cerveri I, D'Armini AM, Viganò M (April 2003). "Pulmonary thromboendarterectomy almost 50 years after the first surgical attempts". Heart. 89 (4): 369–370. doi:10.1136/heart.89.4.369. PMC 1769265. PMID 12639858.
- Balachandran JS, Masa JF, Mokhlesi B (September 2014). "Obesity Hypoventilation Syndrome Epidemiology and Diagnosis". Sleep Medicine Clinics. 9 (3): 341–7. doi:10.1016/j.jsmc.2014.05.007. PMC 4210766. PMID 25360072.
nhlbi.nih.gov
- "What Are the Signs and Symptoms of Pulmonary Hypertension? – NHLBI, NIH". www.nhlbi.nih.gov. Archived from the original on 2016-01-05. Retrieved 2015-12-30.
- "Who Is at Risk for Pulmonary Hypertension?". NHLBI – NIH. 2 August 2011. Archived from the original on 31 July 2017. Retrieved 30 July 2017.
- "Causes and Risk Factors". Health Topics: Pulmonary Hypertension. National Heart, Lung and Blood Institute. National Library of Medicine. 24 March 2022.
- "Treatment". Health Topics: Pulmonary Hypertension. National Heart, Lung and Blood Institute. National Library of Medicine. 24 March 2022.
- NHLBI & What Is Pulmonary Hypertension? 2023 "What Is Pulmonary Hypertension?". Health Topics: Pulmonary Hypertension. National Heart, Lung and Blood Institute. National Library of Medicine. May 2023.
- "Diagnosis". Health Topics: Pulmonary Hypertension. National Heart, Lung and Blood Institute. National Library of Medicine. March 24, 2022.
- "How Is Pulmonary Hypertension Diagnosed? – NHLBI, NIH". www.nhlbi.nih.gov. Archived from the original on 2016-01-05. Retrieved 2015-12-30.
- "How Is Pulmonary Hypertension Diagnosed?". National Heart, Lung, and Blood Institute.
- "How Is Pulmonary Hypertension Treated? – NHLBI, NIH". www.nhlbi.nih.gov. Archived from the original on 2016-01-05. Retrieved 2015-12-30.
ghr.nlm.nih.gov
- "Pulmonary arterial hypertension". Genetics Home Reference. January 2016. Archived from the original on 28 July 2017. Retrieved 30 July 2017.
- Austin ED, Phillips III JA, Loyd JE (2015-12-28). "Pulmonary arterial hypertension". In Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LH, Gripp KW, Amemiya A (eds.). Genetics Home Reference. Archived from the original on 2015-12-24. Retrieved 2015-12-30.

nydailynews.com

"Elaine Kaufman, famed Elaine's restaurateur, dies at age 81". Daily News. 3 December 2010. Archived from the original on 28 August 2016. Retrieved 27 September 2016.

nypost.com

Phull H (July 26, 2016). "She's tethered to an oxygen tank, but her singing career is soaring". New York Post. Archived from the original on August 14, 2016.

oxfordjournals.org

bja.oxfordjournals.org

British Journal of Anaesthesia: "Primary pulmonary hypertension in pregnancy; a role for novel vasodilators" Archived 2011-01-21 at the Wayback Machine March 19, 2011

patient.info

"Pulmonary Hypertension. About Pulmonary Hypertension | Patient". Patient. Archived from the original on 2016-01-02. Retrieved 2015-12-30.

radiopaedia.org

Gaillard F. "Pulmonary hypertension". Radiopaedia. Retrieved 2018-03-12.

reuters.com

"UPDATE 1-Encysive gets Canadian approval for hypertension drug". Reuters. 2008-05-30. Archived from the original on 2007-07-04. Retrieved 2007-07-08.

semanticscholar.org

api.semanticscholar.org

Bordones-Crom A, Patnaik SS, Menon PG, Murali S, Finol E (July 2021). "Morphological Analysis of the Right Ventricular Endocardial Wall in Pulmonary Hypertension". Journal of Biomechanical Engineering. 143 (7). doi:10.1115/1.4050457. PMID 33704381. S2CID 232193407.
Taleb M, Khuder S, Tinkel J, Khouri SJ (March 2013). "The diagnostic accuracy of Doppler echocardiography in assessment of pulmonary artery systolic pressure: a meta-analysis". Echocardiography. 30 (3): 258–265. doi:10.1111/echo.12061. PMID 23227919. S2CID 7460778.
Torres F (October 2007). "Systematic review of randomised, double-blind clinical trials of oral agents conducted in patients with pulmonary arterial hypertension". International Journal of Clinical Practice. 61 (10): 1756–65. doi:10.1111/j.1742-1241.2007.01545.x. PMID 17877662. S2CID 1191543.
Mouratoglou SA, Bayoumy AA, Noordegraaf AV (2021). "Prediction Models and Scores in Pulmonary Hypertension: A Review". Current Pharmaceutical Design. 27 (10): 1266–76. doi:10.2174/1381612824999201105163437. PMID 33155897. S2CID 226272078.
York M, Farber HW (November 2011). "Pulmonary hypertension: screening and evaluation in scleroderma". Current Opinion in Rheumatology. 23 (6): 536–544. doi:10.1097/BOR.0b013e32834ba6a7. PMID 21934501. S2CID 19528958.
Mittoo S, Fell CD (April 2014). "Pulmonary manifestations of systemic lupus erythematosus". Seminars in Respiratory and Critical Care Medicine. 35 (2). MedScape: 249–254. doi:10.1055/s-0034-1371537. PMID 24668539. S2CID 24654448. Archived from the original on 26 October 2015. Retrieved 31 December 2015.
Reynolds PN (February 2011). "Gene therapy for pulmonary hypertension: prospects and challenges". Expert Opinion on Biological Therapy. 11 (2): 133–143. doi:10.1517/14712598.2011.542139. PMID 21219232. S2CID 23641857.

ustransplant.org

"2006 OPTN/SRTR Annual Report". US Scientific Registry of Transplant Recipients. 2006-05-01. Archived from the original on 2010-06-05. Retrieved 2007-03-28.

web.archive.org

"Pulmonary arterial hypertension". Genetics Home Reference. January 2016. Archived from the original on 28 July 2017. Retrieved 30 July 2017.
"What Are the Signs and Symptoms of Pulmonary Hypertension? – NHLBI, NIH". www.nhlbi.nih.gov. Archived from the original on 2016-01-05. Retrieved 2015-12-30.
"Who Is at Risk for Pulmonary Hypertension?". NHLBI – NIH. 2 August 2011. Archived from the original on 31 July 2017. Retrieved 30 July 2017.
Yusuf S, Cairns J, Camm J, Fallen EL, Gersh BJ (2011-09-07). Evidence-Based Cardiology. John Wiley & Sons. p. 70.3(figure). ISBN 978-1-4443-5945-9. Archived from the original on 2016-04-30.
"Primary Pulmonary Hypertension Clinical Presentation: History, Physical Examination, Complications". emedicine.medscape.com. Archived from the original on 2015-11-01. Retrieved 2015-12-30.
Rich S, Rubin LJ, Abenhail L, et al. (1998). Executive summary from the World Symposium on Primary Pulmonary Hypertension (Evian, France, September 6–10, 1998). Geneva: The World Health Organization. Archived from the original on April 8, 2002.
"How Is Pulmonary Hypertension Diagnosed? – NHLBI, NIH". www.nhlbi.nih.gov. Archived from the original on 2016-01-05. Retrieved 2015-12-30.
Austin ED, Phillips III JA, Loyd JE (2015-12-28). "Pulmonary arterial hypertension". In Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LH, Gripp KW, Amemiya A (eds.). Genetics Home Reference. Archived from the original on 2015-12-24. Retrieved 2015-12-30.
Klepper MJ, Cobert B (2010-10-25). Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk. Jones & Bartlett Learning. p. 86. ISBN 978-0-7637-6912-3. Archived from the original on 2016-05-04.
"How Is Pulmonary Hypertension Treated? – NHLBI, NIH". www.nhlbi.nih.gov. Archived from the original on 2016-01-05. Retrieved 2015-12-30.
American College of Chest Physicians; American Thoracic Society (September 2013), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American College of Chest Physicians and American Thoracic Society, archived from the original on 3 November 2013, retrieved 6 January 2013, which cites
- McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. (April 2009). "ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association". Circulation. 119 (16): 2250–94. doi:10.1161/CIRCULATIONAHA.109.192230. PMID 19332472.
- "UPDATE 1-Encysive gets Canadian approval for hypertension drug". Reuters. 2008-05-30. Archived from the original on 2007-07-04. Retrieved 2007-07-08.
- "U.S. Food and Drug Administration Approves Gilead's Letairis Treatment of Pulmonary Arterial Hypertension" (Press release). Gilead Sciences. 2007-06-15. Archived from the original on 2007-09-27. Retrieved 2007-06-16.
- "FDA approves Adcirca (tadalafil) tablets for pulmonary arterial hypertension" (Press release). 2009-05-26. Archived from the original on 2010-12-03. Retrieved 2010-12-06.
- "2006 OPTN/SRTR Annual Report". US Scientific Registry of Transplant Recipients. 2006-05-01. Archived from the original on 2010-06-05. Retrieved 2007-03-28.
- American College of Chest Physicians; American Thoracic Society (September 2013), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American College of Chest Physicians and American Thoracic Society, archived from the original on 3 November 2013, retrieved 6 January 2013
- "Pulmonary Hypertension. About Pulmonary Hypertension | Patient". Patient. Archived from the original on 2016-01-02. Retrieved 2015-12-30.
- British Journal of Anaesthesia: "Primary pulmonary hypertension in pregnancy; a role for novel vasodilators" Archived 2011-01-21 at the Wayback Machine March 19, 2011
- Nannini C. "Lung Disease in Rheumatoid Arthritis". MedScape.com. MedScape. Archived from the original on 8 February 2016. Retrieved 31 December 2015.
- Mittoo S, Fell CD (April 2014). "Pulmonary manifestations of systemic lupus erythematosus". Seminars in Respiratory and Critical Care Medicine. 35 (2). MedScape: 249–254. doi:10.1055/s-0034-1371537. PMID 24668539. S2CID 24654448. Archived from the original on 26 October 2015. Retrieved 31 December 2015.
- "Elaine Kaufman, famed Elaine's restaurateur, dies at age 81". Daily News. 3 December 2010. Archived from the original on 28 August 2016. Retrieved 27 September 2016.
- Folkart BA (21 June 1990). "Ina Balin, 52; Movie and TV Actress Sought Lung Implant". Los Angeles Times. Archived from the original on 11 September 2016. Retrieved 27 September 2016.
- Phull H (July 26, 2016). "She's tethered to an oxygen tank, but her singing career is soaring". New York Post. Archived from the original on August 14, 2016.
- Insdorf A (November 10, 2013). "The Challenges of Chloe Temtchine". The Huffington Post. Archived from the original on September 18, 2016.

who.int

Rich S, Rubin LJ, Abenhail L, et al. (1998). Executive summary from the World Symposium on Primary Pulmonary Hypertension (Evian, France, September 6–10, 1998). Geneva: The World Health Organization. Archived from the original on April 8, 2002.

Pulmonary hypertension (English Wikipedia)

archive.org

books.google.com

cbsnews.com

choosingwisely.org

doi.org

fda.gov

accessdata.fda.gov

gilead.com

handle.net

hdl.handle.net

huffingtonpost.com

jnj.com

latimes.com

articles.latimes.com

lung.org

medlineplus.gov

medscape.com

emedicine.medscape.com

medscape.com

merck.com

news-medical.net

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

nhlbi.nih.gov

ghr.nlm.nih.gov

nydailynews.com

nypost.com

oxfordjournals.org

bja.oxfordjournals.org

patient.info

radiopaedia.org

reuters.com

semanticscholar.org

api.semanticscholar.org

ustransplant.org

web.archive.org

who.int